Missouri Cannabis: $5.42/g Blended, 90%+ Capture, and the Low-Price Island Between a Dry State and an Over-Taxed One

Missouri's cannabis market generated $1.52 billion in 2025 — $1.34 billion adult-use, $174 million medical — against an estimated resident demand the framework puts near 280 million grams. That works out to a blended price of about $5.42 per gram and resident capture north of 90%, approaching full displacement. The number that makes Missouri unusual isn't the price or the capture rate. It's the geography: Missouri is the low-price legal island wedged between prohibition Kansas and the over-taxed Illinois metro-east, and demand flows across both borders toward it.

Market Overview

Missouri voters approved medical cannabis in 2018 (Amendment 2) and adult-use in November 2022 (Amendment 3), with adult-use sales launching in February 2023. The transition was among the fastest and cleanest in the country: adult-use went from zero to roughly $115 million a month within its first year and has held that level since. More than two years in, Missouri is a mature market operating at a plateau — monthly adult-use sales have bounced between $110 and $124 million for over a year, rising only about 4% over the most recent six months.

Key metrics:

• $1,517.82M in 2025 sales (Medical $173.69M + Adult-use $1,344.13M) — reported directly by the Missouri Department of Health and Senior Services (DHSS)
• ~$5.42/g blended price (medical spend-per-patient, corroborated by adult-use menu pricing)
• ~280 million grams estimated annual volume (sales ÷ price; Missouri publishes no gram-level weight data)
• 90%+ estimated resident capture, approaching full displacement
• 238 licensed dispensaries statewide (DHSS licensed-facilities portal, June 2026)
• Density: 5.3 stores per 100,000 adults 21+
• Revenue per store: ~$6.38 million annually
• 6% state adult-use excise tax plus local options up to 3%
• Adults 21+: ~4.5 million

Flower Pricing

Missouri's blended price of about $5.42 per gram is best understood as a modeled effective flower-equivalent price, corroborated by real purchasing behavior — not a statewide average the state publishes. It rests on two independent legs. The first is the medical math: $173.69 million in 2025 medical sales across 87,745 active patient cardholders (DHSS, June 2026) works out to roughly $1,980 per patient per year, or about $5.42 per gram at a one-gram-per-day consumption baseline. The second is direct observation of how Missourians actually buy. Single-gram menu listings can badly overstate realized price in a market this discount- and bulk-driven; major retailers' Missouri specials routinely price eighths and half-ounces in the mid-$4 to low-$5 per gram range, squarely consistent with the derived figure. Because Missouri publishes dollar sales but no gram-level volume, this should be read as an estimated effective price grounded in two methods, not a reported one.

That places Missouri in the middle of the national price distribution, but the more important comparison is regional. Illinois, directly across the Mississippi from the St. Louis metro, carries one of the most punishing tax structures in the country and a blended price near $5.72 — with flower running considerably higher once Illinois's potency-based excise is layered on. Kansas, on Missouri's western edge, has no legal cannabis market at all. Missouri sits between them as the low-price option, and as the pricing section below on capture shows, that gradient does real work.

Tax Structure

Missouri applies a 6% state excise tax on adult-use retail sales, with local jurisdictions permitted to add up to 3% more. Medical cannabis is taxed at a lower 4% rate. By national standards this is a light touch — roughly a third of Illinois's effective burden — and it is a deliberate part of why Missouri prices land where they do.

• 6% state excise on adult-use, plus up to 3% local
• 4% tax on medical
• Effective adult-use burden generally under 10%, among the lowest of any adult-use state

The constitutional structure directs adult-use excise revenue, after program operating costs, in equal thirds to the Missouri Veterans Commission, the Public Defender System, and DHSS health programs. That low rate is the mirror image of the Illinois story: where Illinois taxed its market into a persistent price disadvantage, Missouri's restraint helped it convert its resident base quickly and then pull demand inward from its neighbors.

Total Addressable Market

Applying the framework's consumption baseline — 18% participation at 1.0 gram per day across the adult population — to Missouri's roughly 4.5 million adults 21+:

• 4,500,000 adults 21+
• 810,000 estimated regular consumers (18%)
• ~296 million grams annual resident demand

Against approximately 280 million grams of estimated legal volume (the $1.52 billion in sales divided by the $5.42 blended price), Missouri is selling at roughly 95% of resident demand — and given the flat, slightly rising sales curve, the framework reads this as a market at or approaching full resident capture. There is no steep growth left in the line that would indicate a large untapped resident base; the market has converted nearly everyone it is going to convert.

Missouri's estimated legal market capture: 90%+, approaching full displacement.

A note on method: this capture figure is derived, not reported. With the effective price established independently (above), the gram estimate and capture rate follow from it rather than being assumed. The figure is held at 90%+ rather than a hard 100% precisely because the sales line is still creeping upward — a sliver of conversion, or of inbound border demand, is still being added.

Revenue Trend

Missouri's monthly data tells the cleanest medical-to-adult-use cannibalization story in the framework. Medical sales peaked around $40 million a month in late 2022, just before adult-use launched. The moment recreational sales began in February 2023, medical began a steep, uninterrupted decline — to roughly $11 million a month by late 2025 — while adult-use vaulted to and held around $115 million. Medical didn't grow alongside recreational; it was absorbed by it.

Cumulative sales since program inception have surpassed $5.5 billion. The pattern reinforces a recurring framework finding: medical programs function largely as a licensing and access on-ramp, not as a distinct, durable demand pool. Once adult-use opens, the medical channel collapses to the small core of patients who benefit from its tax advantage and higher possession limits.

Dispensary Density

Missouri operates 238 licensed dispensaries against roughly 4.5 million adults — a density of 5.3 stores per 100,000, comfortably above the 3-4 per 100,000 threshold below which access begins to suppress capture, and generating about $6.38 million per store annually. That per-store revenue is high for the density, which is itself a signal: Missouri stores are moving more product than a purely resident market their size should support.

Missouri's combination of moderate density and unusually high revenue per store is the statistical fingerprint of the border dynamic: fewer stores than the saturated western markets, but each one moving far more product than its local population alone would buy.

The geographic distribution is the tell. Of the 238 dispensaries, 124 — more than half — sit in the two metro areas that hug Missouri's bleed borders: 71 in the St. Louis metro facing Illinois, and 53 in the Kansas City metro facing Kansas. Operators have built where the cross-border demand is, not merely where Missouri residents are.

Home Cultivation

Missouri permits home cultivation for registered cardholders only — roughly 13,200 patient and 2,200 consumer cultivators as of mid-2026, a few percent of the consumer base. At Missouri's prices growing rarely pencils out, and the share is too small to move demand, capture, or the price estimate either way.

The Low-Price Island

Missouri's capture sitting at the top of its resident-demand band is not an accident of modeling. It reflects genuine inbound demand from both neighbors, drawn by the two failure modes the framework tracks most closely — prohibition and tax-structure failure — operating simultaneously on opposite borders.

To the west, Kansas has no legal cannabis market of any kind. Kansans cross into Missouri to buy in numbers significant enough to draw sustained press coverage; thousands of Kansas residents purchase cannabis in Missouri, and the flow has persisted despite Kansas enforcement at the border. This is the same prohibition-adjacent inflow seen where New Mexico meets Texas.

To the east, Illinois is legal but expensive. Its tax structure pushes blended prices well above Missouri's, and metro-east Illinois residents cross the river into the St. Louis market for cheaper product; the price differential has been explicitly cited as luring out-of-state sales into Missouri. Where the Kansas flow is driven by prohibition, the Illinois flow is driven purely by price — the same dynamic that makes Missouri's low excise rate a competitive weapon.

The exact share of Missouri sales attributable to out-of-state buyers can't be measured from published data, and this analysis doesn't assign it a number. But the direction is unambiguous and well documented: Missouri is a net importer of cannabis demand, the low-price island between a dry state and an over-taxed one.

The Bottom Line

Missouri is what a well-structured launch looks like at maturity. A fast medical-to-adult-use conversion, a deliberately light tax, and competitive pricing converted the resident market quickly and then turned Missouri into a regional magnet. At roughly $5.42 per gram and 90%-plus resident capture, the market has largely finished the job of displacing resident illicit demand, and its continued slight growth is increasingly a story about its neighbors rather than its own residents.

The variable that defines Missouri's future isn't conversion — that's nearly done — but exposure. A meaningful share of its sales depends on Kansas staying dry and Illinois staying expensive. If either neighbor changes its policy, the inbound demand that holds Missouri at the top of its band would have somewhere else to go.

This analysis applies the Dan K Reports Cannabis Market Framework. For methodology, assumptions, and the complete state-by-state comparison, see the framework documentation.